All lobbying filings
THE KPM GROUP DC LLC
Lobbying for INOZYME PHARMA · Treatments for PPi-Adenosine Pathway, ENPP1 Deficiency, ABCC6 Deficiency, & calciphylaxis.
Filing
Q3 terminationNo activity
Reporting period
3rd Quarter 2025
July 1 - Sep 30 · Posted Oct 17, 2025
Money reported
None
Registrations and no-activity reports carry no figure.
Client based in
Massachusetts
Representation ended
Jul 1, 2025
The registrant reported terminating its work for this client.
Lobbying activity
0
No itemized activity in this filing.